Zdrowie i gospodarka · 30/09/2021

FDA Announces Fee Rate for Material Threat Medical Countermeasure Priority Review Voucher for Fiscal Year 2022

The US Food and Drug Administration (FDA) has set the fee rate for using a material threat medical countermeasure priority review voucher for the fiscal year 2022, based on the average costs incurred by the agency to review priority and non-priority applications in the previous year.